Glucose

There are 2,526 papers on glucose in aging research: 628 trials and 946 observational studies in people, 469 in animals, 15 in cells, 365 reviews. The newest story, Nov 17, 2026: “Dementia burden rose worldwide as populations grew and aged”.

Biomarker

2,526 papers study it14,409 more mention it479 findings

MeSH

1,469 new papers in 30 daysSee all 16,935 papers on glucose

At a glance

Human studies link plasma glucose with brain age gap and glucose with fragility fractures. A trial reports lower glucose with walking football in adults over 60. Human trials of time-restricted feeding and resveratrol report both glucose reductions and no clear effect, while ketone-drink trials report reductions.

479 findings in 413 papers from 1986 to 2026, 59 of them since April 2026

“Overall, individuals in the high-risk group were at higher risk of progression to T2D.”
Glycemia-based predictors of T2D development in adults with obesity and prediabetes: SURMOUNT-1 post hoc analysisJournal of the Endocrine Society2026doi:10.1210/jendso/bvag190
  • Human trial628
  • Humans946
  • Animals432
  • Model organisms37
  • Cells15
  • In silico43

Interventions

183

Caloric restriction

downin mice8no changein humans2no changein mice2downin rats2+5−75% to −20%

17 studies
  1. Caloric restriction showed no clear effect on glucose in humans (excess weight) (P > 0.05).

    “no intervention changed these metabolic parameters (P > 0.05).”

    Human trialexcess weightthree monthsn = 105

    Effects of different nutritional interventions on abdominal adiposity components and metabolic parameters

    Nutrition (Burbank, Los Angeles County, Calif.)

  2. Caloric restriction showed no clear effect on glucose in humans (86±7 to 84±11 mg/dl, p=0.33, d=0.3).

    “Blood glucose (86±7 to 84±11 mg/dl, p=0.33, d=0.3) and blood lipids (total cholesterol (196±49 to 203±54 mg/dl, p=0.16, d=0.4) and TC/HDL (4.9±2.4 to 6.1±4.7, p=0.13, d=0.4)) were unchanged.”

    Human trial3 daysn = 15

    The Effects of Short-Term Caloric Restriction on Cardiometabolic Health in Overweight/Obese Men and Women

    Preprints.orgPreprint

  3. Caloric restriction decreases glucose in rats (maternal CR during lactation).

    “Both groups showed a reduction in serum glucose levels in the offspring, as well as a reduction in the activity of superoxide dismutase (SOD) in the hypothalamus.”

    Animalsmaternal CR during lactation

    Caloric Restriction and Intermittent Fasting During Lactation Leads to Malnutrition, Hypothalamic Redox Imbalance and Impaired Glucose Metabolism in Male and Female Offspring of Wistar Rats

    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

  4. Caloric restriction decreases glucose in mice fed high-fat diet compared to CR-HFD (-75%).

    “75% lower glucose, and 450% more hepatic Akkermansia bacteria (P < 0.05).”

    Animalsin mice fed high-fat diet compared to CR-HFD2 wkmalesn = 20

    An Energy-Restricted Diet Including Yogurt, Fruit, and Vegetables Alleviates High-Fat Diet-Induced Metabolic Syndrome in Mice by Modulating the Gut Microbiota

    The Journal of nutrition

  5. Caloric restriction showed no clear effect on glucose in OVX-HFD rats.

    “it could not diminish the BG level in the OVX-HFD group”

    Animalsin OVX-HFD rats16 weeks

    Substitution of calorie restriction for protective effects of estrogen on cardiometabolic risk factors and oxidative stress in obese postmenopausal rat model

    Life sciences

  6. Caloric restriction decreases glucose in mice.

    “DR mice displayed lower plasma glucose levels, compared with AL groups.”

    Animals

    Early-onset dietary restriction maintains mitochondrial health, autophagy and ER function in the left ventricle during aging

    The Journal of nutritional biochemistry

  7. Caloric restriction decreases glucose in PNGR/IPGR male and female offspring.

    “In PNGR/IPGR plasma/CSF glucose and lactate decreased while ketones increased in (M) and (F) (PN21, PN50).”

    Animalsin PNGR/IPGR male and female offspring

    Early life nutrient restriction impairs blood-brain metabolic profile and neurobehavior predisposing to Alzheimer's disease with aging

    Brain research

  8. Caloric restriction increases glucose in mice (DBA/2 mice).

    “increased fasting levels in DBA/2 mice”

    AnimalsDBA/2 mice1-5 weeksmales

    The impact of acute caloric restriction on the metabolic phenotype in male C57BL/6 and DBA/2 mice

    Mechanisms of ageing and development

  9. Caloric restriction decreases glucose in mice (C57BL/6 mice).

    “decreased fasting blood glucose in C57BL/6 mice”

    AnimalsC57BL/6 mice1-5 weeksmales

    The impact of acute caloric restriction on the metabolic phenotype in male C57BL/6 and DBA/2 mice

    Mechanisms of ageing and development

  10. Caloric restriction showed no clear effect on glucose in mice.

    “did not alter plasma levels of glucose, insulin, IGF-I, testosterone, progesterone or estradiol”

    Animalsplasma20%

    Effects of mild calorie restriction on reproduction, plasma parameters and hepatic gene expression in mice with altered GH/IGF-I axis

    Mechanisms of ageing and development

All 19

More on Caloric restriction

Resveratrol

downin humans6no changein humans4downin rats2upin humans1+3

15 studies
  1. Resveratrol showed no clear effect on glucose.

    “No significant changes were observed in glucose, insulin, HOMA-IR, SOD, MDA, allantoin, GST, GSH, GSH-Px, urine 8-iso-PGF2α, or 8-OHdG among groups.”

    Human trial8 weeksn = 168

    A Randomized Trial on Resveratrol Supplement Affecting Lipid Profile and Other Metabolic Markers in Subjects with Dyslipidemia

    Nutrients

  2. Resveratrol showed no clear effect on glucose in individuals with dyslipidemia.

    “Nevertheless, we failed to detect significant differences in glucose, insulin, or oxidative stress biomarkers between the resveratrol groups and placebo.”

    Human trialin individuals with dyslipidemia8 weeks

    A Randomized Trial on Resveratrol Supplement Affecting Lipid Profile and Other Metabolic Markers in Subjects with Dyslipidemia

    Nutrients

  3. Resveratrol showed no clear effect on glucose in humans.

    “Overall, these results show that the variables and markers examined were not significantly modified after resveratrol supplementation.”

    Human trial1-monthmalesn = 19

    Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors

    Nutrients

  4. Resveratrol increases glucose in humans after physical fitness test.

    “Plasma glucose and triglycerides levels were increased after the FT in firefighters supplemented with RES”

    Human trialafter physical fitness testplasma100 mg/day90 days

    Effects of chronic resveratrol supplementation in military firefighters undergo a physical fitness test--a placebo-controlled, double blind study

    Chemico-biological interactions

  5. Resveratrol decreases glucose in humans.

    “There were significant differences in changes in blood glucose levels at post-treatment among participants in the moderate and high dose resveratrol groups compared to participants receiving the placebo (p = 0.02 and p = 0.01, respectively) with/without adjustment of the baseline glucose levels.”

    Human trial90 daysn = 32

    Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study

    Experimental gerontology

  6. Resveratrol decreases glucose in humans (overweight, older adults) (ps<0.05).

    “Compared to placebo, glucose levels were significantly lower at post-treatment among participants randomized to both resveratrol conditions, with and without adjustment for the corresponding baseline values (ps<0.05).”

    Human trialoverweight, older adultscapsule300mg/day and 1000mg/day90daysn = 32

    Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study

    Experimental gerontology

  7. Resveratrol decreases glucose in humans (menopause).

    “It also decreases fasting blood glucose levels, insulin levels, total cholesterol, triglycerides, and adipocyte hypertrophy.”

    Reviewmenopause

    The Effects of Resveratrol on Menopausal Cardio-metabolic Changes: A Systematic Review

    Cardiovascular & hematological disorders drug targets

  8. Resveratrol decreases glucose in oophorectomy mice.

    “in addition to glucose, total cholesterol, and triglyceride levels”

    Animalsin oophorectomy micegavageplasma-serumtwelve weeksfemales

    Oral supplementation with resveratrol improves hormonal profile and increases expression of genes associated with thermogenesis in oophorectomy mice

    Molecular and cellular endocrinology

  9. Resveratrol showed no clear effect on glucose in STZ-induced diabetic rats.

    “Oral resveratrol could not improve the changes in the bodyweights and blood-glucose concentrations”

    Animalsin STZ-induced diabetic ratsoral12 weeks

    Anti-inflammation properties of resveratrol in the detrusor smooth muscle of the diabetic rat

    International urology and nephrology

  10. Resveratrol decreases glucose in T2DM rats.

    “Treatment with resveratrol attenuated the increased glucose levels (pre- and post-prandial), impaired glucose tolerance, HbA1c, and decreased the body weights of the T2DM rats.”

    Animalsin T2DM rats50 or 100 mg·kg−14 weeks

    Resveratrol attenuates behavioural impairment associated with learning and memory in rats with diabetes induced by a high-fat diet and streptozotocin

    British journal of pharmacology

All 18

More on Resveratrol

Exercise

downin humans10upin humans1no changein rats1

12 studies
  1. Exercise improves glucose in humans (type 2 diabetes).

    “All intervention groups showed significant improvements in glucose and lipid parameters (P < 0.05).”

    Human trialtype 2 diabetescombined training90-min sessionsn = 85

    The role of combined training timing strategies in mitigating the dawn phenomenon in older adults with type 2 diabetes in Nanjing, China: a randomized controlled trial

    Preventive medicine reports

  2. Exercise decreases glucose in humans (type 2 diabetes mellitus) (-42.31 mg/dL).

    “Foot exercises reduced blood glucose levels by an average of 42.31 mg/dL”

    Human trialtype 2 diabetes mellitusn = 32

    Effectiveness of Foot Exercises and Acupressure on Blood Glucose Levels in Older Adults With Type 2 Diabetes Mellitus: A Quasi-Experimental Study at PRSLU Karawang

    Jurnal Ners

  3. Exercise decreases glucose in humans.

    “Venous glucose, insulin, and HOMA‐IR were lower after exercise relative to the rest condition (p < 0.001, all); however, there were no differences found for venous lactate concentration between rest and exercise conditions (p = 0.27).”

    Human trial2 weeksn = 36

    Postprandial exercise attenuates glucose and insulin and is associated with age, cognitive function, and extracellular/intracellular body water

    Physiological reports

  4. Exercise decreases glucose in humans (p = 0.003).

    “Postprandial exercise decreased insulin and glucose in younger and older adults compared to postprandial sitting (p < 0.001, p = 0.003).”

    Human trialn = 36

    Postprandial exercise attenuates glucose and insulin and is associated with age, cognitive function, and extracellular/intracellular body water

    Physiological reports

  5. Exercise decreases glucose in humans (post-HFHC) (NE: Δ∼21 ± 26 %; EX: Δ∼12 ± 18 %, P = 0·027).

    “EX had attenuated GLU independent of age (NE: Δ∼21 ± 26 %; EX: Δ∼12 ± 18 %, P = 0·027).”

    Human trialpost-HFHC12 hours prior to HFHC

    Acute exercise improves glucose and TAG metabolism in young and older adults following high-fat, high-carbohydrate meal intake

    The British journal of nutrition

  6. Exercise is linked with lower glucose in humans (type 1 diabetes) (-1.06±0.89 mmol/l).

    “Independent of type, exercise decreased glucose by -1.06±0.89 mmol/l.”

    Humanstype 1 diabetesduring exercise41.5% femalesn = 3,248

    Exercise in type 1 diabetes: real-world data on glucose levels and hypoglycaemia risk from over 420,000 exercise sessions

    Diabetologia

  7. Exercise decreases glucose in humans (high-frequency interruption strategies).

    “High-frequency interruption strategies showed the most favourable acute effects on glucose and insulin responses”

    Reviewhigh-frequency interruption strategiesn = 1,369

    Effects of different sedentary interruption strategies on blood glucose, insulin, and triglycerides: A network meta-analysis

    Journal of sports sciences

  8. Exercise decreases glucose in humans (compared with prolonged sedentary behavior) (Hedges' g = -0.37, 95% CI -0.53 to -0.22).

    “exercise snacks significantly reduced postprandial glucose AUC (Hedges' g = -0.37, 95% CI -0.53 to -0.22, P < 0.01”

    Reviewcompared with prolonged sedentary behavior

    Acute Effects of Exercise Snacks on Glucose and Lipid Metabolic Outcomes in Individuals with Metabolic Disorders: A Systematic Review and Meta-Analysis

    Diabetes, metabolic syndrome and obesity : targets and therapy

  9. Exercise decreases glucose in humans (acute studies, pre- to post-exercise) (MD 0.53 mmol/L, 95% CI 0.10 to 0.96).

    “afternoon exercise was associated with greater reductions in glucose levels from pre- to post-exercise (MD 0.53 mmol/L, 95% CI 0.10 to 0.96, I2 = 21%, p = 0.02)”

    Reviewacute studies, pre- to post-exercise

    Influence of Morning and Afternoon Exercise on Body Composition and Metabolic Health: A Systematic Review and Meta-Analysis

    Sports medicine - open

  10. Exercise decreases glucose in humans (interrupting prolonged sitting) (Hedge's g = -0.726, 95% CI -1.167 to -0.285).

    “Short activity breaks significantly reduced postprandial glucose (Hedge's g = -0.726, 95% CI -1.167 to -0.285)”

    Reviewinterrupting prolonged sitting

    Acute effects of interrupting prolonged sitting with short bouts of physical activity on postprandial metabolism in sedentary adults: A multi-level meta-analysis

    Public health

All 13

More on Exercise

Resistance training

downin humans7upin humans1no changein humans1

9 studies
  1. Resistance training increases glucose in humans (5.20±0.63 vs. 5.46±0.51).

    “In contrast, the MJ group exhibited a significant increase in triglyceride and fasting plasma glucose (FPG) (1.13±0.35 vs. 1.44±0.44; 5.20±0.63 vs. 5.46±0.51; p = 0.001, p = 0.002, respectively).”

    Human trial12 weeksn = 19

    Self-efficacy enhanced multi-joint exercise improves fitness and cardiometabolic health in overweight and obese older adults: a randomised controlled trial

    medRxivPreprint

  2. Resistance training increases glucose in humans (overweight and obesity).

    “while fasting glucose increased in the multi-joint exercise group (MJ).”

    Human trialoverweight and obesitymulti-joint exercise group (MJ)12-weekn = 33

    Self-efficacy enhanced multi-joint exercise improves fitness and cardiometabolic health in overweight and obese older adults: a randomised controlled trial

    medRxivPreprint

  3. Resistance training decreases glucose in humans (-0.2% vs -4.9%).

    “10-15RM elicited greater glucose reductions (-0.2% vs -4.9%, P < 0.05)”

    Human trial10-15 repetitions maximum12 wkfemalesn = 101

    Resistance Training for Older Women: Do Adaptive Responses Support the ACSM and NSCA Position Stands?

    Medicine and science in sports and exercise

  4. Resistance training decreases glucose in humans after a high-fat meal (5.6 ± 2.5 mg/dL lower).

    “the average GLU response was 5.6 ± 2.5 mg/dL lower in RE versus CON and was inversely related to SMM across the sample (r = -0.615)”

    Human trialafter a high-fat mealmales

    Resistance exercise attenuates postprandial metabolic responses to a high-fat meal similarly in younger and older men

    Nutrition research (New York, N.Y.)

  5. Resistance training showed no clear effect on glucose in humans.

    “There were no observed differences in glucose, testosterone, GH, and lactate concentrations both at 2 and 24 h after the execution of the two training methods.”

    Human trial24 hmalesn = 12

    Metabolic and hormonal responses to different resistance training systems in elderly men

    The aging male : the official journal of the International Society for the Study of the Aging Male

  6. Resistance training decreases glucose in humans (obese older women) (TG=90.8±11.1mg/dL vs. CG=97.9±6.9mg/dL, P<0.05).

    “glucose (TG=90.8±11.1mg/dL vs. CG=97.9±6.9mg/dL)”

    Human trialobese older women8weeksfemalesn = 38

    Resistance training improves inflammatory level, lipid and glycemic profiles in obese older women: A randomized controlled trial

    Experimental gerontology

  7. Resistance training decreases glucose in humans (TD=-4.5% vs. PR=-1.9%).

    “GLU (TD=-4.5% vs. PR=-1.9%), TG (TD=-18.0% vs. PR=-11.7%), HDL-C (TD=+10.6 vs. PR=+7.8%), LDL-C (TD=-23.3% vs. PR=-21.0%)”

    Human trial8 weeksfemalesn = 25

    Traditional and pyramidal resistance training systems improve muscle quality and metabolic biomarkers in older women: A randomized crossover study

    Experimental gerontology

  8. Resistance training decreases glucose in humans with metabolic syndrome or at cardiometabolic risk (MD -9.02 mg/dL).

    “fasting glucose (MD=-9.02 mg/dL [-15.48 to -2.56])”

    Reviewwith metabolic syndrome or at cardiometabolic riskn = 1,134

    Optimizing Elastic Band Resistance Training for Metabolic Syndrome Components in Older Adults: A Systematic Review, Meta-Analysis, and Meta-Regression of Randomized Controlled Trials

    Archives of physical medicine and rehabilitation

  9. Resistance training decreases glucose in humans (type 2 diabetes) (MD: -1.43 mg/dl, P = 0.04).

    “and fasting blood glucose (mean differences: MD: -1.43 mg/dl, P = 0.04)”

    Reviewtype 2 diabetes

    The efficacy of resistance exercise training on metabolic health, body composition, and muscle strength in older adults with type 2 diabetes: A systematic review and Meta-Analysis

    Diabetes research and clinical practice

  10. Resistance training decreases glucose in humans (Overweight/obese postmenopausal and older females; compared with control) (Hedges' g -1.19, 95% CI -1.63 to -0.74).

    “HVRT demonstrated higher effect sizes than LVRT for glucose (HVRT = -1.19; 95%CI: -1.63 to -0.74; LVRT = -0.78; 95%CI:-1.15 to -0.41)”

    ReviewOverweight/obese postmenopausal and older females; compared with controlhigh-volume resistance training∼77 sets/weekfemales

    Effect of resistance training volume on body adiposity, metabolic risk, and inflammation in postmenopausal and older females: Systematic review and meta-analysis of randomized controlled trials

    Journal of sport and health science

More on Resistance training

(r)-3-hydroxybutyl (r)-3-hydroxybutyrate

downin humans5no changein humans1downin mice1

7 studies
  1. (r)-3-hydroxybutyl (r)-3-hydroxybutyrate decreases glucose in humans (OGTT-induced hyperglycemia) (P < 0.01).

    “In both groups, KME reduced plasma glucose area under the curve (P < 0.01)”

    Human trialOGTT-induced hyperglycemia482 mg/kgfemales

    Ketone monoester ingestion improves endothelial function during hyperglycemia in females with polycystic ovary syndrome

    American journal of physiology. Endocrinology and metabolism

  2. (r)-3-hydroxybutyl (r)-3-hydroxybutyrate showed no clear effect on glucose in adults with type 2 diabetes.

    “There were no differences in the primary outcomes of plasma glucose concentration (acutely) or serum fructosamine (glycemic control across 14 days) between conditions.”

    Human trialin adults with type 2 diabetesplasma0.3 g/kg body massacuten = 18

    The effect of acute and 14-day exogenous ketone supplementation on glycemic control in adults with type 2 diabetes: two randomized controlled trials

    American journal of physiology. Endocrinology and metabolism

  3. (r)-3-hydroxybutyl (r)-3-hydroxybutyrate decreases glucose in humans (healthy).

    “Blood glucose was reduced after consumption of each supplement”

    Human trialhealthywhole-blood10 grams of active ingredient240 minutes post-supplementationn = 12

    The Effect of Novel Exogenous Ketone Supplements on Blood Beta-Hydroxybutyrate and Glucose

    Journal of dietary supplements

  4. (r)-3-hydroxybutyl (r)-3-hydroxybutyrate decreases glucose in humans (postexercise recovery).

    “glucose concentrations lower, with KETONE versus CONTROL”

    Human trialpostexercise recoverydrinkserum0.29 g/kg immediately postexercise and at 1 and 2 h postexercise4 hmalesn = 9

    Ketone monoester ingestion increases postexercise serum erythropoietin concentrations in healthy men

    American journal of physiology. Endocrinology and metabolism

  5. (r)-3-hydroxybutyl (r)-3-hydroxybutyrate decreases glucose in humans (5.00 (1.01) vs 3.56 (0.66) mmol/L).

    “post-intervention blood glucose, lactate, and non-esterified fatty acid concentrations were significantly lower than pre-intervention values: mean (SD) = 5.00 (1.01) vs 3.56 (0.66) mmol/L, p ≪ 0.001”

    Human trial30 minn = 12

    Evaluation of Acute Supplementation With the Ketone Ester (R)-3-Hydroxybutyl-(R)-3-Hydroxybutyrate (deltaG) in Healthy Volunteers by Cardiac and Skeletal Muscle ³¹P Magnetic Resonance Spectroscopy

    Frontiers in physiology

  6. (r)-3-hydroxybutyl (r)-3-hydroxybutyrate decreases glucose in humans (-28.8%, p < 0.001).

    “post-intervention blood glucose, lactate and non-esterified fatty acid concentrations decreased significantly (-28.8%, p ≪ 0.001; -28.2%, p = 0.02; and -49.1%, p ≪ 0.001, respectively)”

    Human trialdrinkwhole-blood25 g30 min

    Evaluation of Acute Supplementation With the Ketone Ester (R)-3-Hydroxybutyl-(R)-3-Hydroxybutyrate (deltaG) in Healthy Volunteers by Cardiac and Skeletal Muscle ³¹P Magnetic Resonance Spectroscopy

    Frontiers in physiology

  7. (r)-3-hydroxybutyl (r)-3-hydroxybutyrate decreases glucose in humans during an oral glucose tolerance test (-11%, P = 0.002).

    “Compared with the control drink, KE reduced glucose (-11%, P = 0.002)”

    Human trialduring an oral glucose tolerance test0.45 mL/kg body weightn = 15

    A ketone monoester drink reduces the glycemic response to an oral glucose challenge in individuals with obesity: a randomized trial

    The American journal of clinical nutrition

  8. (r)-3-hydroxybutyl (r)-3-hydroxybutyrate decreases glucose in mice (postexercise, concomitant with glucose).

    “The KE-treated group showed significantly lower postadministration blood glucose concentrations and higher plasma insulin concentrations compared with those of the Con-treated group.”

    Animalspostexercise, concomitant with glucose2.0 g/kg BWmales

    Postexercise ketone monoester administration concomitant with glucose stimulates glycogen repletion in soleus muscle in mice

    American journal of physiology. Cell physiology

More on (r)-3-hydroxybutyl (r)-3-hydroxybutyrate

Time-restricted feeding

downin humans2downin mice2downin flies1no changein humans1

6 studies
  1. Time-restricted feeding decreases glucose in veterans with spinal cord injury and obesity (-7 ± 3 mg/dL).

    “Twenty-four-hour glucose levels decreased by 7 ± 3 mg/dL (p = 0.02) and the GMI decreased by 0.2 ± 0.1% (p = 0.02), both with large effect sizes (d ~0.8).”

    Human trialin veterans with spinal cord injury and obesity6-week

    Time-Restricted Eating Is Feasible and Acceptable and Improves Glycemic Control in Veterans with Spinal Cord Injury and Obesity: A Pilot Trial

    Nutrients

  2. Time-restricted feeding decreases glucose in humans (veterans with spinal cord injury and obesity) (-7 ± 3 mg/dL, p = 0.02).

    “improved several markers of glycemic control, including 24 h glucose levels (-7 ± 3 mg/dL, p = 0.02)”

    Human trialveterans with spinal cord injury and obesity6-weekn = 14

    Time-Restricted Eating Is Feasible and Acceptable and Improves Glycemic Control in Veterans with Spinal Cord Injury and Obesity: A Pilot Trial

    Nutrients

  3. Time-restricted feeding decreases glucose in humans during 3-hour OGTT (Δ = − 5.3 ± 14.7 mg/dL vs Δ = 4.9 ± 13.6 mg/dL).

    “Mean glucose levels during the OGTT after the glucose bolus, were significantly lower from baseline to post-intervention in EOF (Δ = − 5.3 ± 14.7 mg/dL) compared to the control group (Δ = 4.9 ± 13.6 mg/dL, group × visit p = 0.028,, ).”

    Human trialduring 3-hour OGTTaverage duration of 7.5 ± 0.7 weeksn = 39

    Sleep-Aligned Extended Overnight Fasting Improves Nighttime and Daytime Cardiometabolic Function

    Arteriosclerosis, thrombosis, and vascular biology

  4. Time-restricted feeding decreases glucose in humans (overweight/obese).

    “including lower nighttime heart rate, higher heart rate variability, lower nighttime cortisol, and during the Oral Glucose Tolerance Test, lower glucose level, and higher 30-minute insulinogenic index”

    Human trialoverweight/obese7.5 weeksn = 39

    Sleep-Aligned Extended Overnight Fasting Improves Nighttime and Daytime Cardiometabolic Function

    Arteriosclerosis, thrombosis, and vascular biology

  5. Time-restricted feeding showed no clear effect on glucose in humans.

    “Similarly, the glucose levels did not exhibit significant changes.”

    Human trial12 weeksn = 5

    Calorie Restriction and Time-Restricted Feeding: Effective Interventions in Overweight or Obese Patients Undergoing Radiotherapy Treatment with Curative Intent for Cancer

    Nutrients

  6. Time-restricted feeding decreases glucose in high-fat diet-induced obesity.

    “TRF lowered fasting blood glucose and reduced liver lipid accumulation.”

    Animalsin high-fat diet-induced obesity10-weekfemales

    Impact of time-restricted feeding on metabolic health and adipose tissue metabolism in aged female mice with high-fat diet-induced obesity

    The Journal of physiology

  7. Time-restricted feeding decreases glucose in mice.

    “TRF also reduced blood glucose levels in aged males, but not in aged females”

    Animals6 weeksmales

    Time-restricted feeding rescues sociability deficits and reduces neuroinflammation in aged mice

    Neurobiology of aging

  8. Time-restricted feeding decreases glucose in high-fat diet-fed flies switched to control diet.

    “Flies with metabolic damage that received TRF showed lower total triglyceride content, Nlaz expression, circulating glucose, and weight compared to Ad libitum.”

    Model organismsin high-fat diet-fed flies switched to control dietseven days

    "Effect of time-restricted feeding on high-fat diet-induced metabolic dysfunction in Drosophila melanogaster"

    Biochimica et biophysica acta. Molecular basis of disease

More on Time-restricted feeding

Metformin

downin humans3downin reviews2no changein rats1

6 studies
  1. Metformin decreases glucose in humans (5.48 ± 0.12 vs. 6.68 ± 0.18 mmol/L).

    “with a reduction of glucose values (5.48 ± 0.12 vs. 6.68 ± 0.18 mmol/L, p <0.05”

    Human trial12 months

    Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics Patients

    Frontiers in physiology

  2. Metformin decreases glucose in humans (Obese patients with pre-diabetes receiving a hypocaloric diet).

    “a significant reduction of glucose values, HOMA-IR, and inflammatory markers”

    Human trialObese patients with pre-diabetes receiving a hypocaloric diet12 monthsn = 20

    Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics Patients

    Frontiers in physiology

  3. Metformin decreases glucose in humans (recently detected type II diabetics).

    “Both creatine and metformin decreased glucose concentrations to similar levels at all time points vs. basal glucose values”

    Human trialrecently detected type II diabetics2x500 mg/day5 days

    Comparison of antihyperglycemic effects of creatine and metformin in type II diabetic patients

    Clinical and investigative medicine. Medecine clinique et experimentale

  4. Metformin showed no clear effect on glucose in rats.

    “improved muscle endurance in «Rotarod» test ( p < 0.05) against the background of unchanged glucose levels.”

    Animals70 mg/kg30 daysmales

    Study of the effect of metformin in small doses on the behavioral characteristics and biochemical parameters of rats

    Drug development & registration

  5. Metformin decreases glucose.

    “the liver has been acknowledged as the main location where metformin reduces glucose levels”

    Review

    Understanding the action mechanisms of metformin in the gastrointestinal tract

    Frontiers in pharmacology

  6. Metformin decreases glucose.

    “reducing glucose output from the liver”

    Reviewliver

    Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes

    Drug design, development and therapy

  7. Metformin decreases glucose in humans.

    “reducing blood levels of glucose”

    Reviewliver

    Metformin: update on mechanisms of action and repurposing potential

    Nature reviews. Endocrinology

More on Metformin

Intermittent fasting

downin rats2downin dogs1no changein humans1downin mice1+1

6 studies
  1. Intermittent fasting showed no clear effect on glucose in humans (6.1 ± 0.5, 5.7 ± 0.4, and 5.8 ±0.5 mmol/L).

    “Blood glucose measurements was performed at 15:30 and showed no significant differences between the three periods (6.1 ± 0.5, 5.7 ± 0.4, and 5.8 ±0.5 mmol/L, respectively).”

    Human trialmalesn = 8

    The effect of Ramadan intermittent fasting on lipid peroxidation in healthy young men while controlling for diet and sleep: A pilot study

    Annals of thoracic medicine

  2. Intermittent fasting showed no clear effect on glucose in humans (healthy).

    “No significant changes were observed in MDA levels and blood glucose during BL, BL fasting, or Ramadan.”

    Human trialhealthymalesn = 8

    The effect of Ramadan intermittent fasting on lipid peroxidation in healthy young men while controlling for diet and sleep: A pilot study

    Annals of thoracic medicine

  3. Intermittent fasting decreases glucose in mice.

    “IF reduced blood glucose, HbA1c, and cholesterol levels while increasing ketone bodies”

    Animals16-hour daily fasting regimenfour monthsmales

    Uncovering Shared and Tissue-Specific Molecular Adaptations to Intermittent Fasting in Liver, Brain, and Muscle

    eLifePreprint

  4. Intermittent fasting decreases glucose in rats (maternal IF during lactation).

    “Both groups showed a reduction in serum glucose levels in the offspring, as well as a reduction in the activity of superoxide dismutase (SOD) in the hypothalamus.”

    Animalsmaternal IF during lactation

    Caloric Restriction and Intermittent Fasting During Lactation Leads to Malnutrition, Hypothalamic Redox Imbalance and Impaired Glucose Metabolism in Male and Female Offspring of Wistar Rats

    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

  5. Intermittent fasting decreases glucose in rats (dexamethasone-induced osteoporosis).

    “IF for 90 days significantly improved all these parameters (all P<0.05).”

    Animalsdexamethasone-induced osteoporosisserum16-18 hr daily90 daysmales

    Effect of Intermittent Fasting on Glucose Homeostasis and Bone Remodeling in Glucocorticoid-Induced Osteoporosis Rat Model

    Journal of bone metabolism

  6. Intermittent fasting decreases glucose in zebrafish.

    “IF significantly lowered glucose levels while increasing DCAMKL1 in both young and old animals.”

    Animals

    Dietary and Pharmacological Interventions That Inhibit Mammalian Target of Rapamycin Activity Alter the Brain Expression Levels of Neurogenic and Glial Markers in an Age-and Treatment-Dependent Manner

    Rejuvenation research

  7. Intermittent fasting decreases glucose in dogs.

    “Blood glucose and insulin concentrations were lower in IF dogs on a HF diet compared to daily feeding or IF on a LF diet.”

    Animalson high fat medium-chain triglyceride diet, compared with daily feeding or fasting on low fat diet48 hn = 10

    Metabolic and Immunological Effects of Intermittent Fasting on a Ketogenic Diet Containing Medium-Chain Triglycerides in Healthy Dogs

    Frontiers in veterinary science

More on Intermittent fasting

Ketogenic diet

downin humans5upin rats1

6 studies
  1. Ketogenic diet decreases glucose in humans (single-arm study; changes cannot be attributed independently to nutritional ketosis).

    “Glucose decreased after diet initiation”

    Human trialsingle-arm study; changes cannot be attributed independently to nutritional ketosisplasma60 days

    Metabolic and hormonal responses to nutritional ketosis across metabolic phenotypes and sex in adults

    Scientific reports

  2. Ketogenic diet decreases glucose in humans (at -10% weight loss).

    “in glucose concentration at -10% wt loss (-16 vs -3% p=0,045)”

    Human trialat -10% weight loss

    Effects of a Very-Low-Calories Ketogenic Diet on Visceral Adipose and Muscular Tissues in Comparison with a Mediterranean Dietary Intervention

    ADA Scientific Sessions 2025 abstract

  3. Ketogenic diet decreases glucose in humans.

    “Glucose levels were reduced over the 6-weeks for both KD groups and, despite fluctuations across time points, were unchanged in the LFD group at the end of the study.”

    Human trial6 weeks

    The effects of a 6-week controlled, hypocaloric ketogenic diet, with and without exogenous ketone salts, on cognitive performance and mood states in overweight and obese adults

    Frontiers in neuroscience

  4. Ketogenic diet is linked with lower glucose in humans (sought glucose control) (54% (36/67)).

    “36 of 67 (54%) who sought glucose control appeared to achieve the latter”

    Humanssought glucose controln = 67

    Can older patients adopt and maintain a ketogenic diet? An observational study in support of clinical trials in older patients

    Medicine

  5. Ketogenic diet decreases glucose in humans (MD: -7.30 mg/dL [95 % CI -11.62 to -2.98], p=0.0009).

    “and glucose (MD: -7.30 mg/dL [95 % CI -11.62 to -2.98], p=0.0009)”

    Review1 to 20 weeks

    Effect of ketogenic diets on insulin-like growth factor (IGF)-1 in humans: A systematic review and meta-analysis

    Ageing research reviews

  6. Ketogenic diet increases glucose in rats following epinephrine administration.

    “KD-fed rats showed an enhanced elevation in glucose following epinephrine administration.”

    Animalsfollowing epinephrine administration

    Metabolic switching is impaired by aging and facilitated by ketosis independent of glycogen

    Aging

More on Ketogenic diet

High-intensity interval training

downin humans3upin humans2

5 studies
  1. High-intensity interval training decreases glucose in humans (overweight or obesity).

    “Blood glucose and insulin levels also decreased significantly (P < 0.05) in CONC and HIIT compared with CG”

    Human trialoverweight or obesity12 weeksfemalesn = 45

    Effects of high-intensity interval training and concurrent training on body composition and metabolic profile in postmenopausal women with overweight or obesity: a clinical trial

    Exploration of Endocrine and Metabolic Diseases

  2. High-intensity interval training decreases glucose in humans.

    “participants exhibited reduced fasting glucose levels”

    Human trial12 wkfemalesn = 8

    Dissociation between metabolic improvements and mitochondrial transcriptional changes following exercise training in women with polycystic ovary syndrome

    American journal of physiology. Endocrinology and metabolism

  3. High-intensity interval training increases glucose in individuals with type 1 diabetes (167.48 ± 66.96 mg/dL vs CON 150.43 ± 61.69 mg/dL, P = 0.021).

    “Average whole-day glucose levels were higher on the day of HIIT (167.48 ± 66.96 mg/dL; group × time P = 0.021) and MICT (166.46 ± 61.35 mg/dL; group × time P = 0.039) compared with CON”

    Human trialin individuals with type 1 diabetesn = 14

    Metabolic Effects of Isoenergetic High-Intensity Interval Training and Moderate-Intensity Continuous Training in Adults with Type I Diabetes

    Medicine and science in sports and exercise

  4. High-intensity interval training increases glucose in humans (overweight postmenopausal women) (p < 0.05).

    “Significant within-group increases in irisin (p < 0.01), insulin (p < 0.01), and glucose (p < 0.05) were observed following HIIT.”

    Human trialoverweight postmenopausal women20 minfemalesn = 28

    The impact of acute morning versus evening high-intensity interval training on circulating irisin levels and metabolic parameters in overweight postmenopausal women

    Experimental gerontology

  5. High-intensity interval training decreases glucose in humans (5.7 ± 1.3 to 5.3 ± 0.9 mmol/l).

    “HIIT produced a small reduction in SED glucose compared to baseline (5.7 ± 1.3 mmol·l−1 at baseline and 5.3 ± 0.9 mmol·l−1 post-HIIT; Cohen's d = 0.36)”

    Human trial6 weeksmalesn = 22

    High intensity interval training (HIIT) produces small improvements in fasting glucose, insulin, and insulin resistance in sedentary older men but not masters athletes

    Experimental gerontology

More on High-intensity interval training

Ketone monoester

downin humans3

3 studies
  1. Ketone monoester decreases glucose in humans (22.09 ± 10.43 mg/dL).

    “The glucose-suppression magnitude (22.09 ± 10.43 mg/dL) shows that circulating glucose fell by roughly one-fifth of a typical baseline level after KME ingestion, confirming a meaningful but transient hypoglycemic effect.”

    Human trial10 daysn = 16

    Pharmacokinetics and metabolic effects of ketone monoester supplementation: The first simultaneous CKM and CGM study under normal diet and activities

    Metabolism open

  2. Ketone monoester decreases glucose in humans.

    “Granger causality analysis confirmed that KME supplementation acutely suppressed ISF glucose, with an initial effect at 5 min and a sustained post-dose suppression phase between 25 and 55 min.”

    Human trialinterstitial fluidn = 20

    Pharmacokinetics and metabolic effects of ketone monoester supplementation: The first simultaneous CKM and CGM study under normal diet and activities

    Metabolism open

  3. Ketone monoester decreases glucose in humans (healthy weight and overweight/obesity).

    “Acute ketone monoester supplementation elevated levels of blood BHB and prefrontal connectomes and decreased levels of glucose”

    Human trialhealthy weight and overweight/obesity395 mg/kgn = 40

    Acute ketone monoester supplementation in young adults: modulating metabolic and neurocognitive functions across body weights

    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme

  4. Ketone monoester decreases glucose in humans (-9.4%, P = 0.03, d = 0.56).

    “resulted in decreases in blood glucose AUC (-9.4%, P = 0.03, d = 0.56)”

    Human trialsupplement0.45 mL/kg2.5 hn = 19

    Prior ingestion of a ketone monoester supplement reduces postprandial glycemic responses in young healthy-weight individuals

    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme

More on Ketone monoester

Low-carbohydrate diet

downin humans1no changein humans1downin mice1

3 studies
  1. Low-carbohydrate diet decreases glucose in humans (−18.6 ± 86.2 vs −100.0 ± 57.7 mg/dL).

    “The mean difference of 2‐h glucose between the baseline and 18 months was significantly greater in the LCD group than the TDD group (−18.6 ± 86.2 vs −100.0 ± 57.7 mg/dL, P < 0.05; Table ).”

    Human trial18 monthsn = 44

    A 90 g/day low-carbohydrate diet improved glycemic control without decreasing frailty in older patients with type 2 diabetes: A secondary analysis of a randomized controlled trial

    Journal of diabetes investigation

  2. Low-carbohydrate diet decreases glucose in humans (type 2 diabetes) (-100.0 ± 57.7 vs -18.6 ± 86.2 mg/dL, P < 0.05).

    “The 18-month mean change from baseline was statistically significant for 2-h glucose (-100.0 ± 57.7 vs -18.6 ± 86.2 mg/dL)”

    Human trialtype 2 diabetes18 monthsn = 42

    A 90 g/day low-carbohydrate diet improved glycemic control without decreasing frailty in older patients with type 2 diabetes: A secondary analysis of a randomized controlled trial

    Journal of diabetes investigation

  3. Low-carbohydrate diet showed no clear effect on glucose in humans.

    “Fasting glucose, HOMA-IR, total cholesterol, HDL-cholesterol, and LDL cholesterol decreased to the same extent between the three dietary interventions.”

    Human trial12 weeksn = 302

    The effect of dietary carbohydrate and calorie restriction on weight and metabolic health in overweight/obese individuals: a multi-center randomized controlled trial

    BMC medicine

  4. Low-carbohydrate diet decreases glucose in mice (miR-146a knock-out).

    “associated with increased lymphocytes and reduced monocytes, granulocytes, blood glucose and insulin levels”

    AnimalsmiR-146a knock-out

    A low carbohydrate diet high in fish oil and soy protein delays inflammation, hematopoietic stem cell depletion, and mortality in miR-146a knock-out mice

    Frontiers in nutrition

More on Low-carbohydrate diet

Empagliflozin

downin humans1downin rats1downin reviews1

3 studies
  1. Empagliflozin decreases glucose in individuals with HNF1A-MODY as add-on treatment (-2.3 mmol/L (95% CI 1.3 to 3.3)).

    “Compared with placebo, empagliflozin lowered the mean glucose level 2.3 mmol/L (95% CI 1.3 to 3.3; P = 0.0001).”

    Human trialin individuals with HNF1A-MODY as add-on treatment25 mg4 weeksn = 18

    Drug lowered blood sugar in an inherited form of diabetes

    Diabetes care

  2. Empagliflozin decreases glucose in scopolamine and heavy metal mixture-induced Alzheimer's disease rats.

    “notable suppressive impact of EMPA on lipid peroxidation, acetylcholinesterase, glucose levels, phosphorylated tau protein, pro-inflammatory cytokines, and neuropathological changes”

    Animalsin scopolamine and heavy metal mixture-induced Alzheimer's disease ratsmales

    Neuroprotective Effect of Empagliflozin/Rivastigmine in Alzheimer's Disease Rat Model: Optimization of Multifaceted Mechanism of Action

    Drug development research

  3. Empagliflozin decreases glucose.

    “EMPA not only effectively lowers blood glucose levels but also confers substantial cardiovascular benefits”

    Review

    Roles of Empagliflozin in Diabetic Cardiomyopathy: A Review

    Current vascular pharmacology

More on Empagliflozin

Aerobic exercise

downin humans2upin humans1

3 studies
  1. Aerobic exercise decreases glucose in humans (at 1 h postprandially).

    “At an hour postprandially, the T‐HFHC and P‐HFHC were higher than the T‐HFHC + EX and the P‐HFHC + EX (all p's <0.050).”

    Human trialat 1 h postprandially6 hn = 10

    The impact of an acute high polyphenol, high fiber meal with and without aerobic exercise on metabolism in middle-aged and older adults: A pilot study

    Physiological reports

  2. Aerobic exercise increases glucose in humans (exercise only compared to dual condition task) (mean increase of 9.5% +/- 16.4%, Cohen's D=0.57).

    “Glucose was utilized more in the exercise only task compared to the dual condition task (Visit 2 – Visit 1 difference: mean increase of 9.5% +/- 16.4% in pre-post % change)”

    Human trialexercise only compared to dual condition task10-minutesfemalesn = 10

    EFFECTS OF ACUTE EXERCISE AND A DUAL COGNITIVE TASK ON A NOVEL CIRCULATING BIOMARKER

    GSA 2024 abstract

  3. Aerobic exercise decreases glucose in humans (older adults with type 2 diabetes mellitus) (SMD -1.04, 95% CI -1.27, -0.81).

    “aerobic exercise was effective in improving glucose levels (standardized mean difference [SMD]: -1.04; 95% confidence interval [95% CI] -1.27, -0.81)”

    Reviewolder adults with type 2 diabetes mellitus

    Effects of aerobic exercise on components of the metabolic syndrome in older adults with type 2 diabetes mellitus: systematic review and meta-analysis

    Revista peruana de medicina experimental y salud publica

More on Aerobic exercise

Tirzepatide

downin humans2downin reviews1

3 studies
  1. Tirzepatide decreases glucose in humans (compared with dulaglutide).

    “Compared with dulaglutide, statistically significant reductions in change from baseline in AUC(0–6h) after dose for glucose, insulin, glucagon, C‐peptide and triglycerides AUC(0–6h) were observed at Week 32 in participants randomized to tirzepatide, except in the case of triglycerides with tirzepatide 10 mg”

    Human trialcompared with dulaglutide52 weeksn = 48

    Change in pharmacodynamic variables following once-weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono substudy)

    Diabetes, obesity & metabolism

  2. Tirzepatide decreases glucose in humans (compared with GLP-1 receptor agonist therapy).

    “has demonstrated greater glucose and body weight-lowering properties as compared to GLP-1 receptor agonist therapy”

    Reviewcompared with GLP-1 receptor agonist therapy

    Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double-blind, randomised, placebo-controlled clinical trial

    BMJ open

  3. Tirzepatide decreases glucose.

    “Tirzepatideshowedpotent glucose lowering and weight loss effects within an acceptable safety.”

    Review

    Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment

    Life (Basel, Switzerland)

More on Tirzepatide

All 183

Effects

12

Cognitive function

downin humans1no changein humans1upin humans1

3 studies
  1. Glucose is linked with lower cognitive function in humans.

    “negatively associated with cognitive performance, movement function, and mental health outcomes.”

    Humans

    Metabolomic signatures of brain aging: A multimodal and genetic study

    Molecular psychiatry

  2. Glucose was not clearly linked with cognitive function in humans (normotensive elderly individuals).

    “Blood glucose levels showed no significant effect on cognition (P > 0.05).”

    Humansnormotensive elderly individualsn = 386

    Cognitive function in normotensive elderly adults: a population-based cross-sectional study in rural China

    Frontiers in medicine

  3. Glucose is linked with better cognitive function in humans (foreign-born Latinos) (β=0.01, p < 0.05).

    “glucose (β= 0.01; p < 0.05) and hemoglobin (β= 0.46; p < 0.01) predict better cognitive function among foreign-born Latinos”

    Humansforeign-born Latinos

    Cardiometabolic health, nativity status and cognition among Latinos in the Health and Retirement Study

    GSA 2025 abstract

Mortality

mediatesin humans1no changein humans1

2 studies
  1. Glucose is linked with mortality in humans (explaining 31.7% of the UHI effect on all-cause mortality) (explaining 31.7% of the UHI effect).

    “Glucose emerged as the strongest mediator, explaining 31.7% of the UHI effect on all-cause mortality.”

    Humansexplaining 31.7% of the UHI effect on all-cause mortalityn = 233,137

    Associations of urban heat island and its metabolomic profiles with all-cause and cause-specific mortality in middle-aged and older adults

    Ecotoxicology and environmental safety

  2. Glucose was not clearly linked with mortality in diabetic patients hospitalized for pneumonia.

    “In diabetic patients there is no association between ABG and mortality.”

    Humansin diabetic patients hospitalized for pneumonian = 743

    The prognostic significance of admission blood glucose levels in elderly patients with pneumonia (GAP Study)

    Journal of diabetes and its complications

Kidney failure

mediatesin humans1

1 study
  1. Glucose is linked with kidney failure in humans (Mediation of the relationship between body mass index and renal failure) (7.02% mediated).

    “five acted as mediators in the relationship between BMI and renal failure: cystatin C (12.34%), glucose (7.02%), glycated hemoglobin (HbA1c) (6.83%), diastolic blood pressure (6.37%)”

    HumansMediation of the relationship between body mass index and renal failure

    A Mendelian randomization analysis of the causal effect of body mass index on biomarkers and renal failure risk

    Medicine

More on Kidney failure

Regional brain volume

downin humans1

1 study
  1. Glucose is linked with lower regional brain volume in humans (across 80 regions).

    “Higher glucose concentrations were also associated with reduced regional brain volumes across 80 cortical, subcortical, and cerebellar regions.”

    Humans

    Metabolomic signatures of brain aging: A multimodal and genetic study

    Molecular psychiatry

Brain age

upin silico1

1 study
  1. Glucose increases brain age in silico.

    “two-sample Mendelian randomization (MR) provided evidence supporting a potential causal role of glucose in accelerating brain aging.”

    In silico

    Metabolomic signatures of brain aging: A multimodal and genetic study

    Molecular psychiatry

More on Brain age

Sleep efficiency

downin humans1

1 study
  1. Glucose is linked with lower sleep efficiency in humans (free-living adults with overweight or obesity at risk of type 2 diabetes) (B = -0.05% per 1 mg/dL increase).

    “daytime mean glucose was associated with later wake-up time (0.008 [0.002, 0.014] h; p = 0.008), longer sleep period time (0.006 [0.000, 0.012] h; p = 0.039) and lower sleep efficiency (-0.05% [-0.08%, -0.01%] %; p = 0.005)”

    Humansfree-living adults with overweight or obesity at risk of type 2 diabetes14 daysn = 388

    Sleep Efficiency Predicts Next-Day Glycaemia and Daytime Glycaemia Influences Sleep in Free-Living Adults at Risk of Type 2 Diabetes

    Diabetes, obesity & metabolism

More on Sleep efficiency

Autophagy

downin humans1

1 study
  1. Glucose decreases autophagy in humans.

    “elevated glucose levels promote proliferation, epithelial-mesenchymal transition, increase invasion, and reduce autophagy in bladder cancer cells”

    Reviewbladder cancer cells

    The interplay of dietary sugar, chronic inflammation, and bladder cancer: mechanistic insights, evidence, and prevention strategies

    Frontiers in immunology

More on Autophagy

Working memory

downin C. aethiops1

1 study
  1. Glucose impairs working memory in C. aethiops (F(1,10)=21.13, p<0.001).

    “working memory declined with increasing glucose levels at older ages (glucose baseline: F(1,10)=21.13, p <0.001; AUC F(1,10)=12.72, p = 0.005)”

    Animalsfemales

    Age, glucose tolerance, and cognitive performance in vervet monkeys

    AAIC 2025 abstract

Perceived facial age

no changein humans1

1 study
  1. Glucose was not clearly linked with perceived facial age in humans (healthy adults).

    “No relationship between the levels of biochemical indicators of glycemia and perceived facial age or aging was found both in men and women”

    Humanshealthy adults

    Perceived facial age and biochemical indicators of glycemia in adult men and women

    Scientific reports

More on Perceived facial age

Glutathione

downin humans1

1 study
  1. Glucose is linked with lower glutathione in humans (at risk for dementia).

    “Increasing glucose and HbA1c levels were associated with reduced GSH concentration in the anterior cingulate.”

    Humansat risk for dementiaanterior cingulate cortex

    Brain oxidative stress and cognitive function in older adults with diabetes and pre-diabetes who are at risk for dementia

    Diabetes research and clinical practice

More on Glutathione

All 12

Upstream

18

Age

upin humans1upin O. cuniculus1downin O. orca1

3 studies
  1. Age is linked with higher glucose in humans (0.212 <= r <= 0.370, p < 0.05).

    “The age increase was positively correlated (0.212 ≤ r ≤ 0.370, p < 0.05) with the clinical markers (total cholesterol, HDL, LDL, VLDL, triacylglyceride, and glucose levels)”

    Humansserumn = 138

    The Aging Process: A Metabolomics Perspective

    Molecules (Basel, Switzerland)

  2. Age increases glucose in O. cuniculus (aging).

    “the highest concentration of blood sugar (glucose) was observed in the third group, compared to the first and second.”

    Animalsagingwhole-bloodmales

    Physiological and Histological Changes in Pancreatic Gland Associated with Ageing in Local Rabbits in Iraq

    Archives of Razi Institute

  3. Age decreases glucose in O. orca across age categories from calf to aged (>30.9 years).

    “Red blood cell parameters and associated renal analytes increased with age, while liver-associated analytes and glucose decreased.”

    Animalsacross age categories from calf to aged (>30.9 years)serum

    Effect of age, sex, and season on the variation in blood analytes of a clinically normal ex situ population of killer whales (Orcinus orca)

    Veterinary clinical pathology

Older age

upin humans2

2 studies
  1. Older age is linked with higher glucose in humans (baseline and 24 h times) (P < 0.05).

    “glucose and urea levels were higher among the older participants than the youth group at baseline and 24 h times (P < 0.05).”

    Humansbaseline and 24 h timesserum

    Biochemical analytes in centrifuged blood samples could be affected by the age of subjects in different time periods and storage temperatures

    Asian journal of transfusion science

  2. Older age is linked with higher glucose in humans after a high-fat meal.

    “The GLU response was greater in the older than younger men at 1 to 5 hours post-meal”

    Humansafter a high-fat meal1 to 5 hours post-mealmales

    Resistance exercise attenuates postprandial metabolic responses to a high-fat meal similarly in younger and older men

    Nutrition research (New York, N.Y.)

HBB

no changein humans1

1 study
  1. HBB was not clearly linked with glucose in humans (rs33950507 heterozygous carriers) (beta=0.01, 95%CI:-0.04-0.06, P=0.72).

    “but not glucose levels (beta=0.01, 95%CI:-0.04-0.06, P=0.72)”

    Humansrs33950507 heterozygous carriers

    HbA1c-based diagnosis of type 2 diabetes and complication risk are distorted in British south Asians due to HbE thalassaemia trait

    medRxivPreprint

More on HBB

Sleep efficiency

downin humans1

1 study
  1. Sleep efficiency is linked with lower glucose in humans (free-living adults with overweight or obesity at risk of type 2 diabetes) (B = -0.05 mg/dL per 1% increase).

    “Each 1% increase in sleep efficiency was associated with lower next-day mean glucose (B [95% CI] = -0.05 [-0.08, -0.01] mg/dL; p = 0.007).”

    Humansfree-living adults with overweight or obesity at risk of type 2 diabetes14 daysn = 388

    Sleep Efficiency Predicts Next-Day Glycaemia and Daytime Glycaemia Influences Sleep in Free-Living Adults at Risk of Type 2 Diabetes

    Diabetes, obesity & metabolism

More on Sleep efficiency

Gestational diabetes mellitus

upin humans1

1 study
  1. Gestational diabetes mellitus is linked with higher glucose in humans (1st week postpartum).

    “Additionally, they demonstrated elevated glucose levels at 3 OGTT time points in comparison with non-GDM mothers.”

    Humans1st week postpartumfemalesn = 70

    Postpartum assessment of insulin resistance indicators in mothers with gestational diabetes: A prospective observational case-control study

    Advances in clinical and experimental medicine : official organ Wroclaw Medical University

More on Gestational diabetes mellitus

Glucose-6-phosphate dehydrogenase deficiency

no changein humans1

1 study
  1. Glucose-6-phosphate dehydrogenase deficiency was not clearly linked with glucose in individuals with G6PD deficiency.

    “Glucose concentrations did not differ between groups.”

    Humansin individuals with G6PD deficiency

    HbA1c underperforms in identifying abnormal glucose tolerance in the presence of G6PD deficiency: Insight from the Africans in America study

    PloS one

More on Glucose-6-phosphate dehydrogenase deficiency

Obesity

downin humans1

1 study
  1. Obesity decreases glucose in humans (upon refeeding after 48 h fast, in obesity vs lean) (P < 0.001).

    “Upon refeeding, individuals with obesity demonstrated lower 2 h postprandial glucose excursions compared to lean participants (P < 0.001).”

    Human trialupon refeeding after 48 h fast, in obesity vs lean

    Metabolic responses to 48 h fasting and refeeding in adults with and without obesity

    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme

More on Obesity

Prediabetes

upin humans1

1 study
  1. Prediabetes increase glucose in humans (compared to normal glycemia) (p=0.028).

    “Compared to NG, preD had higher glucose (p=0.028) at 120 min”

    Human trialcompared to normal glycemia120 min

    Prediabetes Phenotypes Defined by Glucose-Stimulated Insulin Response Using Hyperglycemic Clamp in Healthy Young People

    ADA Scientific Sessions 2025 abstract

More on Prediabetes

Lipocalin-2

no changein humans1

1 study
  1. Lipocalin-2 was not clearly linked with glucose in humans (community-dwelling) (p > .05).

    “There was no significant relationship between LCN2 and sex, glucose levels or body composition (all p > .05).”

    Humanscommunity-dwellingserumn = 124

    Circulating lipocalin-2 across the adult lifespan

    JBMR plus

More on Lipocalin-2

ITP

upin flies1

1 study
  1. ITP increases glucose in flies (gain- and loss-of-function experiments).

    “increases glucose and trehalose”

    Model organismsgain- and loss-of-function experiments

    Ion transport peptide regulates energy intake, expenditure, and metabolic homeostasis in Drosophila

    Genetics

More on ITP

Inflammation

upin humans1

1 study
  1. Inflammation increases glucose in humans (2–5 h after the WDHC meal).

    “The inflammatory state had a meal-dependent effect on glycaemic responses: the high inflammation group had significantly higher postprandial glucose concentrations 2–5 h after the WDHC meal than the low inflammation group (P = 0.006).”

    Human trial2–5 h after the WDHC meal5 hn = 60

    Influence of a proinflammatory state on postprandial outcomes in elderly subjects with a risk phenotype for cardiometabolic diseases

    European journal of nutrition

More on Inflammation

Sarcopenia

upin humans1

1 study
  1. Sarcopenia increases glucose in humans (at rest) (144.64-202.78 vs. 107.70-134.20 mg·dL-1).

    “Glucose levels were significantly elevated in S versus NS at 0, 60 and 75 min (144.64-202.78 vs. 107.70-134.20 mg·dL−1 ) but not insulin.”

    Human trialat restn = 22

    Differences in muscle energy metabolism and metabolic flexibility between sarcopenic and nonsarcopenic older adults

    Journal of cachexia, sarcopenia and muscle

More on Sarcopenia

APOE

no changein humans1

1 study
  1. APOE showed no clear effect on glucose in humans.

    “The glucose iAUC was higher for the WDHC group than for the WDHF and MED groups (p = 0.006), although there was no effect of the APOE genotype.”

    Human trialthree 5-h meal tests

    APOE ɛ4 Is Associated with Postprandial Inflammation in Older Adults with Metabolic Syndrome Traits

    Nutrients

More on APOE

All 18

Associations

111

Male sex

upin humans3+19% glucose

3 studies
  1. Male sex is associated with glucose in humans (+18.6% glucose).

    “Men aged 40–65 years showed the clearest adverse profile compared with women of the same age, including higher glucose (+18.6%)”

    HumansMen compared with womens

    Middle-aged men had fewer preventive visits in Brazilian cohort

    American journal of preventive cardiology

  2. Male sex is associated with glucose in humans (Men compared with women at high or very high cardiovascular risk).

    “Men had significantly higher levels of total cholesterol, low-density lipoprotein cholesterol, triglycerides, and glucose.”

    HumansMen compared with women at high or very high cardiovascular riskn = 17,532

    Lipid profile in mexican women at cardiaovascular risk

    Gaceta medica de Mexico

  3. Male sex is associated with glucose in humans (without diabetes) (110 [103-119] vs 104 [99-108] mg/dL).

    “Compared with females, males had higher mean sensor glucose (110 [103-119] vs 104 [99-108] mg/dL; P < .01)”

    Humanswithout diabetesn = 105

    Continuous Glucose Monitoring-Derived Glycemic Profiles and Correlates in Young Adults Ages 18 to 26 Years

    Journal of diabetes science and technology

Hypertension

upin humans3OR 1.92

3 studies
  1. Glucose is associated with hypertension in multivariable analysis.

    “In multivariable analysis, age and elevated glucose levels were independently associated with hypertension”

    Humansin multivariable analysis

    Comparative Analysis of Cardiometabolic Risk Profiles Among Hypertensive and Normotensive Adults: Cross-Sectional Study

    Interactive journal of medical research

  2. Glucose is associated with hypertension in humans (from the normal state or elevated state).

    “Increasing age, body mass index (BMI) and glucose were associated with the probability of developing hypertension from the normal state or elevated state.”

    Humansfrom the normal state or elevated state

    Multistate Markov model application for blood pressure transition among the Chinese elderly population: a quantitative longitudinal study

    BMJ open

  3. Glucose is associated with hypertension in humans (non-institutionalized Malaysian elderly) (OR 1.92).

    “glucose (OR = 1.92), and triglycerides (OR = 1.27) significantly increased the risk of hypertension in subjects (p < 0.05).”

    Humansnon-institutionalized Malaysian elderlybloodn = 2,322

    Factors Affecting Hypertension among the Malaysian Elderly

    Journal of cardiovascular development and disease

More on Hypertension

Brain age gap

upin humans3

3 studies
  1. Glucose is associated with brain age gap in humans (β = 0.32, P = 9.90 × 10−12).

    “glucose showing the strongest effect (β = 0.32, P = 9.90 × 10−12)”

    Humansplasma

    Metabolomic signatures of brain aging: A multimodal and genetic study

    Molecular psychiatry

  2. Brain age gap is associated with glucose in humans (r = 0.149, p = 0.020).

    “elevated fasting glucose levels (r = 0.149, p = 0.020)”

    Humansn = 458

    Brain Age Gap Associations with Body Composition and Metabolic Indices in an Asian Cohort: An MRI-Based Study

    Archives of gerontology and geriatrics

  3. Brain age gap is associated with glucose in humans.

    “Furthermore, we observed higher brain age gap to be associated with heavy episodic drinking, higher blood pressure, and higher blood glucose.”

    Humans

    Linking Brain Age Gap to Mental and Physical Health in the Berlin Aging Study II

    Frontiers in aging neuroscience

More on Brain age gap

Age

upin C. aethiops1mixedin cynomolgus monkeys1upin humans1

3 studies
  1. Age is associated with glucose in humans.

    “An increase in glucose levels was found in persons of older age groups.”

    Humans

    Age-related changes in the parameters of carbohydrate metabolism and supply of vitamins B1, B2 in residents of two northern regions

    Klinicheskaia laboratornaia diagnostika

  2. Age is associated with glucose in C. aethiops (r(51)=0.57, p<0.001).

    “Age was associated with baseline glucose ( r (51)=0.57, p <0.001)”

    Animalsfemales

    Age, glucose tolerance, and cognitive performance in vervet monkeys

    AAIC 2025 abstract

  3. age is associated with glucose in cynomolgus monkeys (particularly in single-caged animals).

    “Age also had profound effects on glucose, triglyceride and high-density lipoproteins, particularly in single-caged animals.”

    Animalsparticularly in single-caged animals

    Role of social interaction, exercise, diet, and age on developing and untreated diabetes in cynomolgus monkeys

    Experimental gerontology

Dementia

upin humans1upin silico1HR 1.18

2 studies
  1. Glucose is linked with a higher risk of dementia in participants without diabetes (adjusted HR 1.18 (95% CI, 1.04 to 1.33)).

    “Among participants without diabetes, higher average glucose levels within the preceding 5 years were related to an increased risk of dementia (P=0.01)”

    Humansin participants without diabetesmedian follow-up of 6.8 years

    Glucose levels and risk of dementia

    The New England journal of medicine

  2. Glucose is associated with dementia in joint constituent-biomarker network.

    “higher NMR-derived glucose had direct relationships with dementia in the joint constituent-biomarker network.”

    In silicoin joint constituent-biomarker network

    Causal roles of phenotypic age and metabolic health on dementia: a Mendelian randomisation and structure learning study

    medRxivPreprint

More on Dementia

Frailty index

downin mice2

2 studies
  1. Frailty index is associated with glucose in mice (r = -0.63; p = .001).

    “glucose (r = -0.63; p = .001), hematocrit (r = -0.53; p = .001), and hemoglobin (r = -0.45; p = .002) were negatively correlated.”

    Animalsfemales

    High frailty index scores predict mortality and changes in blood-based biomarkers in aging female mice

    The journals of gerontology. Series A, Biological sciences and medical sciences

  2. Frailty index is associated with glucose in mice.

    “Frailty is associated with lower glucose levels in both sexes (p= 4.45e-05).”

    Animalsbloodn = 37

    LONGITUDINAL SEX DIFFERENCES IN FRAILTY AND AGING IN UM-HET3 MICE

    GSA 2024 abstract

More on Frailty index

Physical activity

downin humans2

2 studies
  1. Physical activity is associated with glucose in humans.

    “glucose (B:-0.437; CI:-0.789/-0.124; p < 0.001; R2:0.782)”

    Human trial14 weeksfemalesn = 142

    Physical training improves physical activity levels but is associated with amplification of sedentary behavior in older women

    Frontiers in public health

  2. Physical activity is associated with glucose in humans (without self-reported diabetes).

    “Higher HRV, sleep efficiency, and more steps per day were associated with lower glucose”

    Humanswithout self-reported diabetesn = 46,033

    Association of Wearable Physiological Signals and Glucose Biosensor Data in 46,000 Adults without Self-Reported Diabetes

    ADA Scientific Sessions 2026 abstract

More on Physical activity

Longevity

upin humans1downin humans1

2 studies
  1. Glucose is associated with longevity in humans (compared with individuals aged 92 or older who died before 100).

    “longevity was linked to intermediate levels of ferritin and cholesterol, alongside lower glucose, creatinine, and uric acid levels.”

    Humanscompared with individuals aged 92 or older who died before 100

    Blood-based biomarkers in centenarians and non-centenarians: a matched, population-based retrospective cohort study using primary care records in Catalonia, Spain

    Biogerontology

  2. Longevity is associated with glucose in humans (compared with non-centenarians).

    “exhibiting lower levels of glucose, hemoglobin, glycosylated hemoglobin, and triglycerides in blood analysis compared with non-centenarians.”

    Humanscompared with non-centenariansblood

    Descriptive and predictive analysis identify centenarians' characteristics from the Basque population

    Frontiers in public health

Sarcopenia

upin humans1downin humans1OR 0.988–1.82

2 studies
  1. Glucose is linked with a higher risk of sarcopenia in humans (stage 5 CKD undergoing hemodialysis) (OR=1.82, P=0.04).

    “Regression analyses showed that fasting glycemia increased the risk of sarcopenia by 1.82 times (OR=1.82; P=0.04).”

    Humansstage 5 CKD undergoing hemodialysisn = 23

    Fasting Glycemia, Glycosylated Hemoglobin and Malnutrition Inflammation Are Associated With Sarcopenia in Older People With Chronic Kidney Disease Undergoing Hemodialysis Treatment: A Cross-Sectional Study

    Cureus

  2. Glucose is linked with a lower risk of sarcopenia in humans (OR 0.988, 95% CI 0.979–0.997).

    “and a decreased level of glucose (OR = 0.988, 95% CI [0.979, 0.997]).”

    Humansn = 1,307

    Blood Profiles of Community-Dwelling People with Sarcopenia: Analysis Based on the China Health and Retirement Longitudinal Study

    Gerontology

More on Sarcopenia

Mortality

upin humans2HR 1.13

2 studies
  1. Glucose is linked with a higher risk of mortality in humans (HR 1.13 per SD (95% CI 1.08-1.19)).

    “Linear relationships with all-cause mortality were strongest for C-reactive protein, gamma-glutamyl transferase, glucose and alkaline phosphatase”

    Humans

    Comparison of Familial, Polygenic and Biochemical Predictors of Mortality

    Twin research and human genetics : the official journal of the International Society for Twin Studies

  2. Glucose is linked with a higher risk of mortality in elderly non-diabetic patients hospitalized for pneumonia (aHR 1.3-2.7, p<0.05).

    “In elderly non-diabetic patients hospitalized for pneumonia, moderately and markedly elevated ABG is associated with increased short- and long-term mortality.”

    Humansin elderly non-diabetic patients hospitalized for pneumonian = 1,421

    The prognostic significance of admission blood glucose levels in elderly patients with pneumonia (GAP Study)

    Journal of diabetes and its complications

Type 2 diabetes

upin humans1

1 study
  1. Glucose predicts type 2 diabetes in humans.

    “Overall, individuals in the high-risk group were at higher risk of progression to T2D.”

    Human trial176 weeksn = 1,032

    Glycemia-based predictors of T2D development in adults with obesity and prediabetes: SURMOUNT-1 post hoc analysis

    Journal of the Endocrine Society

More on Type 2 diabetes

Last meal to sleep onset interval

downin humans1

1 study
  1. Last meal to sleep onset interval is associated with glucose in humans (obesity).

    “Each hour increase in the PM meal-Sleep interval was associated with lower overnight (1 AM-5 AM) average glucose.”

    Human trialobesity

    Relationship Between Sleep and Meal Timing with Glycemia Parameters in Individuals with Obesity Participating in a Randomized Time-Restricted Eating Study

    Nutrients

More on Last meal to sleep onset interval

Awakening to first meal interval

downin humans1

1 study
  1. Awakening to first meal interval is associated with glucose in humans (obesity).

    “Each hour increase in the Awake-AM meal interval was associated with lower overnight (1 AM-5 AM) average glucose”

    Human trialobesity

    Relationship Between Sleep and Meal Timing with Glycemia Parameters in Individuals with Obesity Participating in a Randomized Time-Restricted Eating Study

    Nutrients

More on Awakening to first meal interval

Wearable sweat sensor

upin humans1

1 study
  1. Wearable sweat sensor predicts glucose in humans (postprandial metabolic status of healthy participants).

    “Finally, we evaluated the postprandial metabolic status of healthy participants to validate the wearable system for continuous real-time on-body monitoring”

    Human trialpostprandial metabolic status of healthy participants

    A wax-printed Janus paper-based microfluidic wearable sensor for metabolic analysis in sweat

    Biosensors & bioelectronics

More on Wearable sweat sensor

Exercise

upin humans1

1 study
  1. Exercise is associated with glucose in humans.

    “Exercise intensity was positively associated with higher glucose concentrations during training sessions, independent of dietary conditions.”

    Human trialmalesn = 15

    Low-Versus High-Carbohydrate Isocaloric Diets on Continuous Glucose Monitoring Metrics in Healthy Trained Cyclists: A Randomized Crossover Trial

    European journal of sport science

More on Exercise

All 111

Funding

184 grants since 2016

National Institute of Diabetes and Digestive and Kidney Diseases$58.4MNational Institute on Aging$39MJapan Society for the Promotion of Science¥197M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Higher plasma glucose is associated with a larger brain age gap in human observational research; glucose also tracks cardiovascular age in people without self-reported diabetes. Human trials report glucose reductions with exercise, ketone drinks, and fasting-mimicking diets, while time-restricted feeding and resveratrol trials report both reductions and no clear effect.

  2. Summary rewritten as its findings changed.

    As it read before

    Glucose is associated with brain age gap in human observational research and lifespan in a comparative bird preprint, where the association plateaus. Human trials report lower glucose with ketone drinks and fasting-mimicking diets, but reductions or no change with time-restricted feeding and resveratrol.

  3. Summary rewritten as its findings changed.

    As it read before

    A human study links higher plasma glucose to a larger brain age gap; a bird-species preprint reports a glucose–lifespan association that plateaus. A study in female mice links lower glucose to greater frailty. Human trials report glucose reductions with fasting-mimicking diets and acarbose, but acarbose has no effect after intravenous glucose.

  4. Summary rewritten as its findings changed.

    As it read before

    Glucose is associated with retinal and brain age gaps in human studies and with lifespan across bird species, where the association plateaus. A human trial reports lower glucose after exercise in sedentary older women with sarcopenic obesity; cognitive results differ, with impaired working memory in female C. aethiops but a positive association with cognitive function in foreign-born Latinos.

  5. Summary rewritten as its findings changed.

    As it read before

    Reviews describe contrasting glucose responses in humans: no effect of combined aerobic and resistance exercise in women with breast cancer, but reductions with exercise using high-frequency interruption strategies.

Latest

Neuroepidemiology

Dementia burden rose worldwide as populations grew and aged

A systematic analysis covering 204 countries and territories found broadly stable rates after accounting for age, but projected growing burden concentrated at ages 70 and…A systematic analysis covering 204 countries and territories found broadly stable rates after accounting for age, but projected growing burden concentrated at ages 70 and older.

Computational studyAlzheimer's disease

See all 16,935 papers on glucose